US2014012042A1PendingUtilityA1

Calcium Dicarboxylate Ethers

Assignee: WARNER LAMBERT COPriority: Dec 12, 1997Filed: Sep 11, 2013Published: Jan 9, 2014

Est. expiryDec 12, 2017(expired)· nominal 20-yr term from priority

Inventors:Charles L. Bisgaier Roger Schofield Newton

A61K 31/40C07C 59/305A61K 31/44A61K 31/366A61K 31/225A61K 31/401A61K 31/365A61K 31/405A61K 31/194A61P 9/00A61B 5/7275A61K 31/22

PatentIndex Score

Cited by

References

Claims

Abstract

The invention is a pharmaceutical composition comprising a carboxyalkylether which lowers triglycerides and elevated HDL, and a statin which inhibits HMG-CoA reductase, thereby reducing LDL, said composition being useful for treating vascular diseases.

Claims

exact text as granted — not AI-modified

1 - 28 . (canceled) 
     
     
         29 . A compound that is 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt of Formula II: 
       
         
           
           
               
               
           
         
       
       Wherein R 1  is H and x is a number from 0 to 10. 
     
     
         30 . The compound 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt. 
     
     
         31 . The compound 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt hydrate.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.